Mehriban Isgandar
@MehribanIsgand1
Followers
218
Following
1K
Media
140
Statuses
544
MD, PhD 👩🏻⚕️🫀🩺Head of AI & Digital Cardiology WG of Azerbaijan Cardiology Society🇦🇿HFA Young Ambassador, FESC🇪🇺
Baku
Joined October 2020
SGLT2i can reduce the incidence of new-onset diabetes among individuals with cardiovascular or kidney disease. Read more in #EHJ 👉 https://t.co/ITPAx40TVB
@RoccoMontone @ehj_ed #diabetes
1
50
165
#Hypertensive #pregnancy disorder, an under-recognized women specific risk factor for #HeartFailure? @ESC_Journals @HanCardiomd @AmrAbdin10 @GiuseppeGalati_ 📝👇🏻 https://t.co/3BDpQkEK01
1
9
19
All core #GDMT ↓ all-cause🏥in HF 👇🏾 #SGLT2i 4 RCTs @JACCJournals
https://t.co/BSRI6uBsSS RR 0.89 (0.84-0.93) P<0.001 #ARNI 2 RCTs @JAMACardio
https://t.co/Pe21rJA9EW HR 0.92 (0.88-0.97) P=0.002 #nsMRA 3 RCTs @NatureMedicine
https://t.co/6jNxMzHuzb HR 0.95 (0.91-0.99) P=0.025
Should Heart Failure Trials routinely report on all-cause hospitalizations? Should clinicians, guidelines & payers favor interventions that favorably impact cause-specific & all-cause outcomes? https://t.co/R2AOvXZNPB
https://t.co/CemQrsNKKm
@AndrewFoy82 @drjohnm
3
24
46
Results from the European observational SANTORINI study: lipid-lowering therapy use and achievement of risk-based lipid goals increased over 1-year follow-up particularly when combination LLT was used 💊🩺 https://t.co/iqmWZA5IOp
@EJPCEiC @AboyansV @SilCastelletti
1
62
198
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute #HeartFailure
https://t.co/e3tjj6omdz
@CircHF
ahajournals.org
BACKGROUND: Cardiorenal dysfunction with impaired cyclic GMP (cGMP) response is common in patients presenting with acute heart failure (HF). Type V phosphodiesterase (PDEV) is known to be upregulated...
0
1
8
Hypertrophic cardiomyopathy evolving management: @AHAScience /@ACCinTouch vs. @escardio guidelines https://t.co/T7RsOtfLad
#HCM @ESC_Journals
1
15
58
Join us for the Azerbaijan Cardiology Festival on December 13-15, 2024, at the Ritz Carlton, Baku! Stay tuned for more! #Cardiofest #ASC #Cardiology 🗓️ Dec 13-15, 2024 📍 Ritz Carlton, Baku @UlviMirzoyev @Rahimov073 @islamliaysel @yasminrust @MehribanIsgand1 @drnijad @VNazirova
0
4
6
🗞️ The #RevascHeart study : Revascularization and outcomes in ischaemic left ventricular dysfunction after #HeartFailure admission @ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
@HFA_President
https://t.co/gZEZTz863a
3
60
150
I want to believe in an MRA class effect in cardio-kidney disease, but what will be the final tally over 30 yrs? Spironolactone RALES (1999) ✅ TOPCAT ❓❌ BARACK-D ❌ SPIRIT-HF SPIRRIT-HFpEF Finerenone FIDELIO-DKD ✅ FIGARO-DKD ✅ FINEARTS-HF ✅ REDEFINE-HF FINALITY-HF (2028)
6
28
112
Don’t miss this comprehensive webinar by @GMCRosano @AlexMebazaa @WilfriedMullens @BiykemB @JavedButler1 @ShelleyZieroth @HillLoreena @GianluSava @LeclercqEU 💥💥💥@drnijad @cardioceptor @ARakisheva @HanCardiomd @HF_DJurczyk @_antocannata @SotiriaLiori
https://t.co/nK3tVOfKxP
2
9
25
#GCOS2024 #JACCCardioOnc SimPub: #SGLT2i administration was associated with a significantly decreased risk of developing cancer therapy-related cardiac dysfunction in patients with #T2DM and cancer. https://t.co/n4M08SAkUz
#GCOS24 #CardioOnc #Diabetes #T2D @AmmarWB
1
55
116
#ESCCongress2024⚡️:FESC,a speaker on Daily Highlights Session by @AzeCardiology & a moderator at „Drug therapy for HF“ and „🫀felt Genetics“sessions✅@m_piepoli @lamcardio @HanCardiomd @ezmanshariff @cardioceptor @mirvatalasnag @ZainabDakhil2 @_antocannata @ARakisheva @escardio
2
0
9
It was a great pleasure for me to meet my respected colleague @slumberbell from #HFAYoung at #ESCCongress2024
@_antocannata @HanCardiomd @ezmanshariff @SotiriaLiori @M_Sokolski @h_arfsten @HF_DJurczyk @doctorchecho @DjawidHashemi @tugceinci88 @ananeto16 @anllsahin
@escardio
It’s the final day of #ESCCongress, but don’t head out just yet! 🚨 There’s still plenty of top-notch science and presentations happening! 🇦🇿 Dr. @MehribanIsgand1 , from Azerbaijan, from #HFA_young, is here to present and chair some exciting sessions. @escardio is bringing the
0
1
10
Just published🔥Men are from Mars🕺🏻Women are from Venus💃🏻@ElianoNavarese @m_piepoli @GMCRosano @HFA_President @BiykemB @DrMarthaGulati @GiuseppeGalati_ @HanCardiomd @_antocannata @AlexMebazaa @MagdyAbdelhami7 @JavedButler1 @DLBHATTMD @mvaduganathan
https://t.co/co9xhqpTw8
onlinelibrary.wiley.com
Aims A paucity of studies addressed sex-related differences in clinical outcomes in the long term following acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). In...
2
5
14
@JanBiegus @AlexMebazaa @MarcoMetra @FudimMarat For hospitalized HF patients, primacy of GDMT=core therapy, not diuretics alone, successful decongestion as outcome, residual congestion/nonresponse reviewed here: https://t.co/nSfz54N00M Early Uptitration of GDMT Associated With Successful Decongestion and Better Outcomes.
jacc.org
0
2
2
🗞️ #FINEHEARTS_HF Baseline characteristics of pts with #HFmrEF & #HFpEF
https://t.co/kzocseqet1
#EJHF 🔝 Results soon at #ESCCongress
@ESC_Journals @escardio
@GiuseppeGalati_ @AmrAbdin10 @HanCardiomd @HFA_President
@mvaduganathan
0
26
55
If you’re looking for an app for DICOM imaging files anonymization! Let me introduce you to Terrier Anonymizer App! It works for ultrasound/echo too! Microsoft App Store ⬇️ https://t.co/jMyhRcIEs1
1
4
13
Will #GLP1RA join #SGLT2i as standard of care therapy in heart failure with preserved ejection fraction? https://t.co/EamoFg9S3K
4
38
112